1. Home
  2. TCRX vs HOVR Comparison

TCRX vs HOVR Comparison

Compare TCRX & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$2.26

Market Cap

80.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRX
HOVR
Founded
2018
2013
Country
United States
Canada
Employees
N/A
30
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
75.1M
80.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TCRX
HOVR
Price
$0.98
$2.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$7.00
$10.33
AVG Volume (30 Days)
580.7K
3.9M
Earning Date
05-08-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
N/A
EPS
N/A
N/A
Revenue
$10,325,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
266.65
N/A
52 Week Low
$0.88
$0.92
52 Week High
$2.57
$4.18

Technical Indicators

Market Signals
Indicator
TCRX
HOVR
Relative Strength Index (RSI) 40.60 45.76
Support Level $0.91 $1.51
Resistance Level $1.16 $2.63
Average True Range (ATR) 0.06 0.35
MACD -0.01 -0.07
Stochastic Oscillator 21.57 11.08

Price Performance

Historical Comparison
TCRX
HOVR

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

Share on Social Networks: